The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure

Epicardial fat thickness is associated with cardiovascular disease. Mineralocorticoid receptor antagonist (MRA), a pharmaceutical treatment for CVD, was found to have an effect on adipose tissue. Our aim was to analyse the main epicardial fat genesis and inflammation-involved cell markers and their regulation by risk factors and MRA. We included blood and epicardial or subcutaneous fat (EAT or SAT) from 71 patients undergoing heart surgery and blood from 66 patients with heart failure. Cell types (transcripts or proteins) were analysed by real-time polymerase chain reaction or immunohistochemistry. Plasma proteins were analysed by Luminex technology or enzyme-linked immunoassay. Our results showed an upregulation of fatty acid transporter levels after aldosterone-induced genesis. The MRA intake was the main factor associated with lower levels in epicardial fat. On the contrary, MRA upregulated the levels and its secretion of the anti-inflammatory marker intelectin 1 and reduced the proliferation of epicardial fibroblasts. Our results have shown the local MRA intake effect on fatty acid transporters and anti-inflammatory marker levels and the proliferation rate on epicardial fat fibroblasts. They suggest the role of MRA on epicardial fat genesis and remodelling in patients with cardiovascular disease. Translational perspective: the knowledge of epicardial fat genesis and its modulation by drugs might be useful for improving the treatments of cardiovascular disease.

[1]  Yu-jie Zhou,et al.  Omentin-1 Modulates Macrophage Function via Integrin Receptors αvβ3 and αvβ5 and Reverses Plaque Vulnerability in Animal Models of Atherosclerosis , 2021, Frontiers in Cardiovascular Medicine.

[2]  M. Haluzík,et al.  Adipose tissue immune cells in obesity, type 2 diabetes mellitus and cardiovascular diseases. , 2021, The Journal of endocrinology.

[3]  G. Filippatos,et al.  Finerenone Reduces Onset of Atrial Fibrillation in Patients with Chronic Kidney Disease and Type 2 Diabetes. , 2021, Journal of the American College of Cardiology.

[4]  E. Podrez,et al.  Circulating CD36 is increased in hyperlipidemic mice: cellular sources and triggers of release. , 2021, Free radical biology & medicine.

[5]  K. Shimamoto,et al.  Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study , 2021, Scientific Reports.

[6]  L. Janousek,et al.  Statins Directly Influence the Polarization of Adipose Tissue Macrophages: A Role in Chronic Inflammation , 2021, Biomedicines.

[7]  F. Jaisser,et al.  The Mineralocorticoid Receptor Antagonist Eplerenone Suppress Interstitial Fibrosis in Subcutaneous Adipose Tissue in Type 2 Diabetes Patients. , 2020, Diabetes.

[8]  S. Achenbach,et al.  Perivascular Fat Attenuation Index Stratifies Cardiac Risk Associated With High-Risk Plaques in the CRISP-CT Study. , 2020, Journal of the American College of Cardiology.

[9]  B. Nkambule,et al.  Differential expression of glycoprotein IV on monocyte subsets following high-fat diet feeding and the impact of short-term low-dose aspirin treatment , 2020, Metabolism open.

[10]  D. Tregouet,et al.  Reactivation of the Epicardium at the Origin of Myocardial Fibro-Fatty Infiltration During the Atrial Cardiomyopathy , 2020, Circulation research.

[11]  E. Oikonomou,et al.  Artificial intelligence in medical imaging: A radiomic guide to precision phenotyping of cardiovascular disease. , 2020, Cardiovascular research.

[12]  T. Ikejima,et al.  Type I collagen inhibits adipogenic differentiation via YAP activation in vitro , 2020, Journal of cellular physiology.

[13]  H. Malínská,et al.  Polarization of Macrophages in Human Adipose Tissue is Related to the Fatty Acid Spectrum in Membrane Phospholipids , 2019, Nutrients.

[14]  F. Beygui,et al.  Spironolactone and perioperative atrial fibrillation occurrence in cardiac surgery patients: Rationale and design of the ALDOCURE trial. , 2019, American heart journal.

[15]  M. Haluzík,et al.  Changes in omentin levels and its mRNA expression in epicardial adipose tissue in patients undergoing elective cardiac surgery: the influence of type 2 diabetes and coronary heart disease. , 2018, Physiological research.

[16]  G. Frühbeck,et al.  Adipokine dysregulation and adipose tissue inflammation in human obesity , 2018, European journal of clinical investigation.

[17]  M. Haluzík,et al.  The Role of Epicardial Adipose Tissue Lymphocytes in Low-Grade Inflammation and Coronary Artery Disease , 2018, Diabetes.

[18]  L. Allen,et al.  Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry , 2018, Journal of the American Heart Association.

[19]  Lindsey A. Muir,et al.  Frontline Science: Rapid adipose tissue expansion triggers unique proliferation and lipid accumulation profiles in adipose tissue macrophages , 2018, Journal of leukocyte biology.

[20]  Lucio Della Guardia,et al.  Adipocytes properties and crosstalk with immune system in obesity‐related inflammation , 2018, Journal of cellular physiology.

[21]  H. Qian,et al.  CD36 Is a Marker of Human Adipocyte Progenitors with Pronounced Adipogenic and Triglyceride Accumulation Potential , 2017, Stem cells.

[22]  A. Malavazos,et al.  Is epicardial fat depot associated with atrial fibrillation? A systematic review and meta-analysis , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[23]  F. Casanueva,et al.  Orosomucoid as prognosis factor associated with inflammation in acute or nutritional status in chronic heart failure. , 2017, International journal of cardiology.

[24]  Jianbo Yu,et al.  Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis , 2016, Cardiovascular Diabetology.

[25]  Á. Fernández-Trasancos,et al.  Glucose and Inflammatory Cells Decrease Adiponectin in Epicardial Adipose Tissue Cells: Paracrine Consequences on Vascular Endothelium , 2016, Journal of cellular physiology.

[26]  K. Shimamoto,et al.  Local Production of Fatty Acid–Binding Protein 4 in Epicardial/Perivascular Fat and Macrophages Is Linked to Coronary Atherosclerosis , 2016, Arteriosclerosis, thrombosis, and vascular biology.

[27]  K. Clément,et al.  Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location. , 2015, Cardiovascular research.

[28]  S. Gogg,et al.  Insulin resistance and impaired adipogenesis , 2015, Trends in Endocrinology & Metabolism.

[29]  Á. Fernández-Trasancos,et al.  Impaired Adipogenesis and Insulin Resistance in Epicardial Fat‐Mesenchymal Cells From Patients With Cardiovascular Disease , 2014, Journal of cellular physiology.

[30]  H. Sul,et al.  Pref-1, a Gatekeeper of Adipogenesis , 2013, Front. Endocrinol..

[31]  Jeroen J. Bax,et al.  Cardioprotective Properties of Omentin-1 in Type 2 Diabetes: Evidence from Clinical and In Vitro Studies , 2013, PloS one.

[32]  W. Niu,et al.  Impact of Mineralocorticoid Receptor Antagonists on Changes in Cardiac Structure and Function of Left Ventricular Dysfunction: A Meta-analysis of Randomized Controlled Trials , 2013, Circulation. Heart failure.

[33]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[34]  R. Touyz,et al.  Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways: Implications in Diabetes Mellitus–Associated Obesity and Vascular Dysfunction , 2012, Hypertension.

[35]  Tetsuya Kitagawa,et al.  Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. , 2011, Journal of the American College of Cardiology.

[36]  M. Zennaro,et al.  Antiadipogenic effects of the mineralocorticoid receptor antagonist drospirenone: potential implications for the treatment of metabolic syndrome. , 2010, Endocrinology.

[37]  D. Link,et al.  CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. , 2010, The Journal of clinical investigation.

[38]  Paul Schoenhagen,et al.  Left Atrial Epicardial Adiposity and Atrial Fibrillation , 2010, Circulation. Arrhythmia and electrophysiology.

[39]  K. Clément,et al.  Epicardial Adipose Tissue Extent: Relationship With Age, Body Fat Distribution, and Coronaropathy , 2008, Obesity.

[40]  W. Jia,et al.  Macrophage infiltration into adipose tissue may promote angiogenesis for adipose tissue remodeling in obesity. , 2008, American journal of physiology. Endocrinology and metabolism.

[41]  M. Furuhashi,et al.  Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. , 2008, The Journal of clinical investigation.

[42]  Russell A. Carter,et al.  Identification of omentin mRNA in human epicardial adipose tissue: comparison to omentin in subcutaneous, internal mammary artery periadventitial and visceral abdominal depots , 2008, International Journal of Obesity.

[43]  C. White,et al.  Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study. , 2007, Journal of the American College of Cardiology.

[44]  H. Sul,et al.  Pref-1, a preadipocyte secreted factor that inhibits adipogenesis. , 2006, The Journal of nutrition.

[45]  K. Feingold,et al.  Adipocyte Fatty Acid–Binding Protein Expression and Lipid Accumulation Are Increased During Activation of Murine Macrophages by Toll-Like Receptor Agonists , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[46]  F. Leonetti,et al.  Relation between epicardial adipose tissue and left ventricular mass. , 2004, The American journal of cardiology.

[47]  M. Jensen,et al.  Measuring committed preadipocytes in human adipose tissue from severely obese patients by using adipocyte fatty acid binding protein. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[48]  H. Hauner,et al.  Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects. , 2004, Metabolism: clinical and experimental.

[49]  Rick M. Maizels,et al.  Immune Regulation by helminth parasites: cellular and molecular mechanisms , 2003, Nature Reviews Immunology.

[50]  Bruce M. Spiegelman,et al.  Uncoupling of Obesity from Insulin Resistance Through a Targeted Mutation in aP2, the Adipocyte Fatty Acid Binding Protein , 1996, Science.

[51]  P. Gruppuso,et al.  Regulation of preadipocyte factor-1 gene expression during 3T3-L1 cell differentiation. , 1996, Endocrinology.

[52]  J. Gorski,et al.  PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. , 1990, Science.

[53]  P. Leprince,et al.  Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria , 2017, European heart journal.

[54]  Damini Dey,et al.  Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis. , 2012, Atherosclerosis.

[55]  D. Simmons,et al.  Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. , 1993, Blood.